Cassia grandis fruit extract reduces the blood glucose level in alloxan-induced diabetic rats

Biomedicine and Pharmacotherapy

Volumn 103, Issue , 2018, Pages 421-428

  Prada, Ariadna Lafourcade ^a,e   Amado, Jesús Rafael Rodríguez ^a,b   Keita, Hady ^c   Zapata, Edgar Puente ^d   Carvalho, Helison ^e   Lima, Emersom Silva ^b   de Sousa, Tatiane Pereira ^b   Carvalho, José Carlos Tavares ^e  

^a UNIVERSIDAD DE ORIENTE   (Cuba)

^b Universidade da Amazonia   (Brazil)

^c Universidad de la Sierra sur   (Mexico)

^d Medical University of Santiago de Cuba   (Cuba)

^e FEDERAL UNIVERSITY OF AMAPÁ   (Brazil)

Author keywords

Acute toxicity; Antioxidant; Cassia grandis; Hypoglycemic; Glycosidase inhibitor

Indexed keywords

2,3 PENTANEDIONE; ALKALOID DERIVATIVE; ALLOXAN; ALPHA GLUCOSIDASE INHIBITOR; AMINE; AMINO ACID; ANTIDIABETIC AGENT; BENZALDEHYDE; CARBOHYDRATE; CASSIA GRANDIS EXTRACT; COUMARIN DERIVATIVE; FLAVONOID; FURFURAL; GLIBENCLAMIDE; GLUCOSE; HEXANAL; ISOBUTYRIC ACID; ISOPENTYL ALCOHOL; ISOVALERALDEHYDE; ISOVALERIC ACID; LINALOOL; MYRCENE; PHENOL DERIVATIVE; PLANT EXTRACT; RESIN; SABINENE; STEROID; TANNIN DERIVATIVE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CASSIA; CASSIA GRANDIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENCY; DRUG SCREENING; FEMALE; FLUID INTAKE; FRUIT; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; IN VIVO STUDY; LIMIT OF QUANTITATION; MASS FRAGMENTOGRAPHY; NONHUMAN; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REFRACTION INDEX; RELATIVE DENSITY; SINGLE DRUG DOSE; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; ISOLATION AND PURIFICATION; METABOLISM; SPRAGUE DAWLEY RAT; TIME FACTOR;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; CASSIA; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FRUIT; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 85045409526     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2018.04.059     Document Type: Article

References (49)

1. Telo, G.H., Cureau, F.V., de Souza, M.S., Andrade, T.S., Copês, F., Schaan, B.D., Prevalence of diabetes in Brazil over time: a systematic review with meta-analysis. Diabetol. Metab. Syndr. 8:65 (2016), 1–13, 10.1186/s13098-016-0181-1.
2. Negri, G., Diabetes mellitus: plantas e princípios ativos naturais hipoglicemiantes. Braz. J. Pharm. Sci. 41:2 (2005), 121–142.
3. Dixit, P.K., Mittal, S., A comprehensive review on anti-diabetic agents of herbal origin. Int. J. Pharm. Pharm. Sci. 5:2 (2013), 29–32.
4. Ezuruike, U.F., Prieto, J.M., The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J. Ethnopharmacol. 155:2 (2014), 857–924, 10.1016/j.jep.2014.05.055i.
5. Kumavat, U.C., Shimpi, S.N., Jagdale, S.P., Hypoglycemic activity of Cassia javanica Linn. in normal and streptozotocin-induced diabetic rats. J. Adv. Pharm. Technol. Res. 3:1 (2012), 47–51, 10.4103/2231-4040.93562.
6. Pitchai, D., Manikkam, R., Hypoglycemic and insulin mimetic impact of catechin isolated from Cassia fistula: a substantiate in silico approach through docking analysis. Med. Chem. Res. 21:9 (2012), 2238–2250.
7. Gupta, S., Sharma, S.B., Singh, U.R., Bansal, S.K., Effect of Cassia auriculata L. leaves on hyperglycemia-induced atherosclerotic environment in streptozotocin rats. Cardiovasc. Toxicol. 11:4 (2011), 308–315.
8. Salahuddin, Md., Jalalpure, S.S., Gadge, N.B., Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic rats. Can. J. Physiol. Pharmacol. 88:2 (2010), 153–160.
9. Roig, J.T., Plantas medicinales aromáticas o venenosas de Cuba, La Habana, Editorial Científico-Técnica. 1988 pp. 263–264.
10. Cáceres, A., Plantas de Uso Medicinal en Guatemala, vol. 1, 1996, Editora Universitaria, Guatemala pp.115–116.
11. Capó, J.T., Chanfrau, J.R., Mirabal, J.M.G., Ruíz, Z.P., Fernández, S.A., Actividad antianémica de la Cassia grandis L. Rev. Cubana Farm. 38:3 (2004), 130–133.
12. Lodha, S.R., Joshi, S.V., Vyas, B.A., Upadhye, M.C., Kirve, M.S., Salunke, S.S., Kadu, S.K., Rogye, M.V., Assessment of the antidiabetic potential of Cassia grandis using an in vivo model. J. Adv. Pharm. Technol. Res. 1:3 (2010), 330–333, 10.4103/0110-5558.72429.
13. Prada, A.L., Amado, J.R.R., Arranz, J.C.E., State of the art in Cassia grandis Lf. Rev. Cubana Plant. Med. 19:1 (2014), 21–28.
14. Parra, A.V., Ruiz, A.R., López, A.G., Ferrer, J.P., González, V.P., Estudio genotóxico in vitro e in vivo del extracto fluido de Cassia grandis L y el gel de Aloe vera L. Rev. Cubana Plant. Med. 5:3 (2000), 91–96.
15. FNFA, Formulario Nacional de Fito y Apifármacos, Ministerio de Salud Pública de Cuba, La Habana. 2010, Dirección Nacional de Farmacias, Cuba.
16. Harborne, J.B., Phytochemical methods. A Guide to Modern Techniques of Plant Analysis, 1973, Chapman and Hall, New York, USA.
17. Unite State Pharmacopeia (USP), Unite State Pharmacopeia Convention. 2012, Arabswell, New York, USA.
18. British Pharmacopoeia (BP), Her Majesty Stationery Office, London, UK. 2014.
19. OCDE 423, OECD, guideline for testing of chemicals. Acute Oral Toxicity-Acute Toxic Class Method, 423, 2012, 2001.
20. OCDE 407, OECD guideline for the testing of chemicals. Repeated Dose 28-day Oral Toxicity Study in Rodents, 408, 2012, 2008.
21. Allain, C.C., Richmond, N., Rosechloy, P., Cholesterol enzymatic colorimetric test. Chem. Clin. 19:20 (1974), 1350–1361.
22. Hayes, A.W., Kruger, C.L., Principles and methods of toxicology. sixth edition, 2014, CRC Press, NY, USA.
23. Islam, M.S., Wilson, R.D., Experimentally induced rodent models of type 2 diabetes. Joost, H.G., Al-Hasani, H., Schürmann, A., (eds.) Methods in Molecular Biology, Animal Models in Diabetes Research, 2012, Humana Press, NY, USA Chapter 10.
24. Aizman, E., Mor, A., George, J., Kloog, Y., Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells. Eur. J. Pharmacol. 643:1 (2010), 139–144, 10.1016/j.ejphar.2010.06.029.
25. Serreze, D.V., Ottendorfer, E.W., Ellis, T.M., Gauntt, C.J., Atkinson, M.A., Acceleration of type I diabetes by a coxsackievirus infection requires a preexisting critical mass of auto-reactive T-cells in pancreatic islets. Diabetes 49:5 (2000), 708–711.
26. Burits, M., Bucar, F., Antioxidant activity of Nigella sativa essential oil. Phytother. Res. 14:5 (2000), 323–328.
27. Shanty, A., Mohanan, P., Heterocyclic schiff bases as non-toxic antioxidants: solvent effect, structure-activity relationship, and mechanism of action. Spectrochim. Acta Part A 192 (2017), 181–187.
28. Andrade, C.A., Becerra, J.J., Cárdenas, V.R., Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes. J. Ethnopharmacol. 116:1 (2008), 27–32.
29. Águila, Y., Caracterización de una materia prima con propiedades anti anémicas, a partir de un producto natural [Trabajo de Diploma]. 1999, Instituto de Farmacia y Alimentos, Universidad de La Habana, La Habana.
30. Bahadoran, Z., Mirmiran, P., Azizi, F., Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J. Diabetes Metab. Disord. 12:1 (2013), 43–51.
31. Vinayagam, R., Xu, B., Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr. Metab. 12 (2015), 60–77.
32. Pino, J.A., Volatile compounds of Cassia grandis L. f. fruit from Cuba. J. Essent. Oil Res. 22:6 (2010), 599–601.
33. Ganjifrockwala, F.A., Joseph, J.T., George, J.T., Decreased total antioxidant levels and increased oxidative stress in South African type 2 diabetes mellitus patients. J. Endocrinol. Metab. Diabetes South Afr. 22:2 (2017), 21–25.
34. Bermudez, D., Monteagudo, E., Boffill, M., Díaz, C., Roca, S., Betancourt, E., Evaluación de la toxicidad aguda de extractos de plantas medicinales por un método alternativo. Revista Electrónica de Veterinaria 8:3 (2007), 1–7.
35. Mosberg, A.T., Hayes, W.A., Wallace Hayes, A., (eds.) Subchronic Toxicity Testing, in Principles and Methods of Toxicology, 2da. ed, 1989, Raven Press, Ltd., New York, USA.
36. Gad, S.C., Frith, C.H., Goodman, D.G., The mouse. Gad, S.C., (eds.) Animal Models in Toxicology, 2nd ed., 2007, Taylor and Francis Group, LLC, New York p. 25–46, 48–51, 58–72.
37. Bestard, J.D., Manrique, C.E.M., Castillo, A.A., Terga, A.M.P., Betancourt, J.E., Martínez, H.S., Zapata, E.P., Soularit, N.S., Evaluación de la toxicidad aguda oral e irritación sobre mucosa bucal de la solución CM-95 tratada magnéticamente. Acta Toxicol. Argent. 16 (2008), 34–40.
38. Adeneye, A.A., Ajagbonna, O.P., Adeleke, T.I., Bello, S.O., Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats. J. Ethnopharmacol. 105:3 (2006), 374–379.
39. Petterino, C., Argentino, S.A., Clinical chemistry and hematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp. Toxicol. Pathol. 57 (2006), 213–219.
40. Alemán, C., Reference database for the principal physiological indicators in three species of laboratory animal. Lab. Anim. 34:1 (2000), 358–378.
41. Martin, D.W., Mayes, P.A., Rodwell, V.W., Granner, D.K., Harper's Review of Biochemistry. 1985, Lange Medical Publication, Los Altos, California, USA.
42. Mingueneau, M., Chaix, A., Scotti, N., Chaix, J., Reynders, A., Hammond, C., Thimonier, J., Hands-on experiments on glycemic regulation and type 1 diabetes. Adv. Physiol. Educ. 39 (2015), 232–239.
43. Rerup, C.C., Drugs producing diabetes through damage of the insulin-secreting cells. Pharmacol. Rev. 22 (1970), 485–518.
44. Joost, H.G., Al-Hasani, H., Schürmann, A., Animal Models in Diabetes Research. 2012, Humana Press, NY, USA.
45. Yashin, A., Yashin, Y., Xia, X., Nemzer, B., Antioxidant activity of spices and their impact on human health: a review. Antioxidants 6:70 (2017), 1–18.
46. Li, Y., Wen, S., Prasad, K.B., Peng, G., Qian, L.G., Yamahara, J., Roufogalis, B.D., Punica granatum flower extract, a potent α-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J. Ethnopharmacol. 99:2 (2005), 239–244.
47. Kusirisin, W., Srichairatanakool, S., Lerttrakarnnon, P., Lailerd, N., Suttajit, M., Jaikang, C., Chaiyasut, C., Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med. Chem. 5 (2009), 139–147.
48. Cruz, H.J., Licea, P.M.E., Hernández, G.P., Abraham, M.E.A., Yanes, Q.M., Estrés oxidativo y diabetes mellitus. Rev. Mex. Patol. Clin. 58 (2011), 4–15.
49. Rodriguez, J.R., Prada, A.L., Escalona, J.C., Pérez, R., Morris, H., Keita, H., Puente, E., Pinho, C., Tavares, J.C., Antioxidant and hepatoprotective activity of a new tablets formulation from Tamarindus indica L. J. Evid. Based Complementary Altern. Med. 3918219 (2016), 1–7.